Search Results 1051-1060 of 2303 for 搜索引擎关键词搜索技巧咨询邮箱：lgooxc@hotmail.com
About this study. This is an open-label, multicenter, phase 2 clinical trial to evaluate the antitumor activity of brentuximab vedotin as a single agent in ...
The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to ...
Cancer. Bimonthly eNewsletter that focuses on trends and advances in hematology and oncology at Mayo Clinic · Cardiovascular · Clinical Updates · Digestive ...
This noncancerous tumor can sometimes grow on the nerve in the head that affects hearing and balance.
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
SUMMARY. Timothy S. Larson, M.D., studies novel means for the laboratory assessment of kidney function, injury and disease. Dr. Larson's work includes ...
The purpose of this multi-center event-driven study in non-dialysis (ND) participants with anemia associated with chronic kidney disease (CKD) is to evaluate ...
The purpose of this study is to assess the effectiveness of INCMGA00012 in participants with locally advanced or metastatic squamous carcinoma of the anal canal ...
Esophageal cancer — Comprehensive overview covers symptoms, causes, types, risks, treatment of cancer of the esophagus.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.